Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Role of Inflammation in CMML Pathobiology and Progression.
Journal: Current hematologic malignancy reports
Published: July 14, 2025
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.
Journal: British journal of haematology
Published: August 12, 2024
Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 08, 2024
Safety and Efficacy of Direct Oral Anticoagulants Compared to Warfarin in Patients with Venous Thromboembolism and Morbid Obesity.
Journal: International journal of hematology-oncology and stem cell research
Published: May 16, 2024
Biomarker role of maternal soluble human leukocyte antigen G in pre-eclampsia: A meta-analysis.
Journal: Immunity, inflammation and disease
Published: January 02, 2024
Survival and Chemotherapy Response in Metastatic Lung Carcinoids: Insights from the National Cancer Database.
Journal: Hematology/oncology and stem cell therapy
Published: December 27, 2023
Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer.
Journal: Cancers
Published: November 24, 2023
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan.
Journal: Current oncology reports
Published: September 27, 2023
Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia.
Journal: American journal of hematology
Published: August 26, 2023
Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpura.
Journal: EJHaem
Published: June 08, 2023
Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies.
Journal: Journal of hematology
Published: October 01, 2022
Last Updated: 09/26/2026